(1166) The Cost-Effectiveness Evidence of Enhanced Influenza Vaccines in Adults ≥65 Years of Age: A Literature Review and Decision-Making Implications

Staff
Hospital de Niños de Buenos Aires
Belgrano, Ciudad Autonoma de Buenos Aires, Argentina

Pablo de Olavide University
Sevilla, Andalucia, Spain

VHN Consulting
Montreal, Quebec, Canada

Department of Health Sciences, University of Groningen
Groningen, Groningen, Netherlands

Department of Mathematics, University of Trento
Trento, Trentino-Alto Adige, Italy

Hospital de la Línea
Cadiz, Andalucia, Spain

Centro de Estudios para la Prevención y Control de Enfermedades Transmisibles, Isalud University, Buenos Aires, Argentina.
Flores, Ciudad Autonoma de Buenos Aires, Argentina

Global Health Economics and Value Strategy Director
CSL Seqirus Inc.
Summit, New Jersey, United States